Form D · Pharmaceuticals
Viroxis Corp
San Antonio, TX · CIK 0001480932
Offering snapshot reported Apr 22, 2013 · SEC filing
- Reported sold
- $7.8M Offering amount: $7.8M
- Investors reported
- 43 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 23, 2012 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 22, 2013 | Amendment | $7,795,000 | $0vs Apr 11, 2013 | 43 | SEC filing |
| Apr 11, 2013 | Amendment | $7,795,000 | $7,022,315vs May 26, 2010 | 43 | SEC filing |
| Mar 8, 2012 | Initial | $1,010,000 | No comparison | 6 | SEC filing |
| Oct 18, 2010 | Initial | $1,250,000 | No comparison | 1 | SEC filing |
| May 26, 2010 | Initial | $772,685 | No comparison | 1 | SEC filing |
| Jan 14, 2010 | Initial | $500,700 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $117K
- Finders' fees
- $0
- Form D file number
- 021-142612
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Braymen, Lambert & Noel Securities, Ltd. | 124902 | Braymen, Lambert & Noel Securities, Ltd. · CRD 124902 |
Source: Form D, filed Apr 22, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cathy Burzik | Director |
| Paul Castella | Director, Promoter |
| Ian William David Clements | Director, Executive |
| Alan Dean | Director |
| Gary Frashier | Director |
| Charles Goodrich | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:San Antonio, TX, 78258